Profile data is unavailable for this security.
About the company
Dextech Medical AB is a Sweden-based research company specialized in urologic oncology. It is focused on prostate cancer, but also other cancers and non-malignant diseases. It develops drug canditates based on modified carbohydrate molecule combined with active substances. The Company has a patented technology platform, GuaDex, and three drug candidates with patents or patent applications. The portfolio includes: OsteoDex, for treatment of bone metastases in castration resistant prostate cancer (CRPC); SomaDex, based on endogenous hormone, somatostatin, and aimed at treatment of acromegaly, neuroendocrine tumors and palliative treatment of CRPC; and CatDex, for instillation treatment of bladder cancer.
- Revenue in SEK (TTM)0.00
- Net income in SEK-4.71m
- Incorporated2004
- Employees1.00
- LocationDextech Medical ABDag Hammarskjolds Vag 34AUPPSALA 752 37SwedenSWE
- Phone+46 86131304
- Websitehttps://dextechmedical.com/